Evaluating Tools Enabling Early De-Risking in ADC & Antibody-Based Therapy Development

12:45 pm - Wednesday 25th February 2026

  • Application of single-cell resolution screening to discover new high affinity antibodies
  • Real-time functional screening to ensure robust, validated leads
  • Comprehensive libraries of conjugates for fast-track development of new ADCs

Speakers:

Chief Scientific Officer
MI-mAbs